Evidence map›Paper›PMID 37500053›Full record

ArticleThe Journal of thoracic and cardiovascular surgery2023

Early clinical outcomes and molecular smooth muscle cell phenotyping using a prophylactic aortic arch replacement strategy in Loeys-Dietz syndrome.

Albert J Pedroza, Paul Cheng, Alex R Dalal, Kathrin Baeumler, Aya Kino, Emily Tognozzi, Rohan Shad, Nobu Yokoyama, Ken Nakamura, Olivia Mitchel and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of thoracic and cardiovascular surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Transforming growth factor-beta (TGF-β) in the pathogenesis of hereditary thoracic aneurysm disorders.Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Albert J PedrozaDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
Paul ChengDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, Calif.
Alex R DalalDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
Kathrin BaeumlerDepartment of Radiology, Stanford University School of Medicine, Stanford, Calif.
Aya KinoDepartment of Radiology, Stanford University School of Medicine, Stanford, Calif.
Emily TognozziDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
Rohan ShadDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
Nobu YokoyamaDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
Ken NakamuraDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
Olivia MitchelDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
William HiesingerDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
Elena Gallo MacFarlaneDepartment of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
Dominik FleischmannDepartment of Radiology, Stanford University School of Medicine, Stanford, Calif.
Y Joseph WooDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif.
Thomas QuertermousDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, Calif.
Michael P FischbeinDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, Calif. Electronic address: mfischbe@stanford.edu.
Stanford University · USJohns Hopkins University · USStanford Medicine · US

Funding

Stanford Center for Connecting DNA Variants to Function and PhenotypeUM1HG011972 · NHGRI · STANFORD UNIVERSITY · PI JESSE M ENGREITZ, THOMAS QUERTERMOUS · 2021 to 2026
$10.5M
Causal variant association mechanisms in TCF21 binding coronary disease lociR01HL134817 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2017 to 2026
$6.2M
The SMAD3 signaling network in coronary artery disease riskR01HL139478 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2018 to 2026
$3.7M
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease riskR01HL156846 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2021 to 2024
$2.7M
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.R01HL151535 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2021 to 2024
$2.7M
Marfan Aortic Embryologic Origin Influences Aneurysm FormationR01HL157949 · NHLBI · STANFORD UNIVERSITY · PI FISCHBEIN, MICHAEL PETER · 2022 to 2025
$2.6M
Stanford Integrated Cardiovascular/Pulmonary Residency Research Training ProgramR38HL143615 · NHLBI · STANFORD UNIVERSITY · PI Michael Peter Fischbein, Marlene Rabinovitch · 2020 to 2026
$2.2M
LncRNA Transcriptional Mechanisms of Coronary Artery Disease RiskR01HL145708 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2019 to 2022
$1.6M
From Locus to Function: Role of ZEB2 in Human Risk of Coronary Artery DiseaseK08HL153798 · NHLBI · STANFORD UNIVERSITY · PI CHENG, PAUL PO SHENG · 2020 to 2024
$933k
Developmental basis for vascular smooth muscle cell dysfunction in Marfan syndrome aortic aneurysmF32HL154681 · NHLBI · STANFORD UNIVERSITY · PI PEDROZA, ALBERT J. · 2020 to 2021
$137k
Extracellular Matrix Biomechanical Properties Contribute to Aneurysm Formation in Marfan SyndromeF32HL160058 · NHLBI · STANFORD UNIVERSITY · PI DALAL, ALEX R. · 2021 to 2022
$134k
NHGRI NIH HHS UM1 HG011972NHLBI NIH HHS F32 HL154681NHLBI NIH HHS F32 HL160058NHLBI NIH HHS K08 HL153798NHLBI NIH HHS R01 HL134817NHLBI NIH HHS R01 HL139478NHLBI NIH HHS R01 HL145708NHLBI NIH HHS R01 HL151535NHLBI NIH HHS R01 HL156846NHLBI NIH HHS R01 HL157949NHLBI NIH HHS R38 HL143615
6 · The paper itself

Abstract

objectivesPatients with Loeys-Dietz syndrome demonstrate a heightened risk of distal thoracic aortic events after valve-sparing aortic root replacement. This study assesses the clinical risks and hemodynamic consequences of a prophylactic aortic arch replacement strategy in Loeys-Dietz syndrome and characterizes smooth muscle cell phenotype in Loeys-Dietz syndrome aneurysmal and normal-sized downstream aorta.

methodsPatients with genetically confirmed Loeys-Dietz syndrome (n = 8) underwent prophylactic aortic arch replacement during valve-sparing aortic root replacement. Four-dimensional flow magnetic resonance imaging studies were performed in 4 patients with Loeys-Dietz syndrome (valve-sparing aortic root replacement + arch) and compared with patients with contemporary Marfan syndrome (valve-sparing aortic root replacement only, n = 5) and control patients (without aortopathy, n = 5). Aortic tissues from 4 patients with Loeys-Dietz syndrome and 2 organ donors were processed for anatomically segmented single-cell RNA sequencing and histologic assessment.

resultsPatients with Loeys-Dietz syndrome valve-sparing aortic root replacement + arch had no deaths, major morbidity, or aortic events in a median of 2 years follow-up. Four-dimensional magnetic resonance imaging demonstrated altered flow parameters in patients with postoperative aortopathy relative to controls, but no clear deleterious changes due to arch replacement. Integrated analysis of aortic single-cell RNA sequencing data (>49,000 cells) identified a continuum of abnormal smooth muscle cell phenotypic modulation in Loeys-Dietz syndrome defined by reduced contractility and enriched extracellular matrix synthesis, adhesion receptors, and transforming growth factor-beta signaling. These modulated smooth muscle cells populated the Loeys-Dietz syndrome tunica media with gradually reduced density from the overtly aneurysmal root to the nondilated arch.

conclusionsPatients with Loeys-Dietz syndrome demonstrated excellent surgical outcomes without overt downstream flow or shear stress disturbances after concomitant valve-sparing aortic root replacement + arch operations. Abnormal smooth muscle cell-mediated aortic remodeling occurs within the normal diameter, clinically at-risk Loeys-Dietz syndrome arch segment. These initial clinical and pathophysiologic findings support concomitant arch replacement in Loeys-Dietz syndrome.

Indexed as

Loeys-Dietz SyndromeMarfan SyndromeAortaAorta, ThoracicHumansVascular Surgical Proceduresaortic aneurysmaortic archaortic root replacementLoeys-Dietz syndromeRNA sequencingsmooth muscle cell

Identifiers

PMID37500053
PMCPMC11888900
OpenAlexW4385237553

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.